| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13550a2e931b7820247a58278354ee62 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ceffc71ea259d6c4b42aa877db2d22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd9277619b7e73a6c1d1fea2d86ffac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5702b0e9268cac19528d790e40aa272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9b2e5b2de642726eccbf0cbbae3b97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7f3aaa8fe6049fa884b8c15df4bb26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbfb0b41f620306aa6733850520aeab |
| publicationDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2006265814-B2 |
| titleOfInvention |
GLP-1 pharmaceutical compositions |
| abstract |
The present invention is directed to peptide analogues of glucagon-like peptide-1 , the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues. |
| priorityDate |
2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |